Morettini Micaela, Göbl Christian, Kautzky-Willer Alexandra, Pacini Giovanni, Tura Andrea, Burattini Laura
Department of Information Engineering, Università Politecnica delle Marche, Ancona 60131, Italy.
Division of Obstetrics and Feto-maternal Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna A-1090, Austria.
Math Biosci Eng. 2019 Dec 10;17(2):1604-1615. doi: 10.3934/mbe.2020084.
Women with a previous history of gestational diabetes mellitus (GDM) have increased risk of developing GDM in future pregnancies (i.e. recurrent GDM) and also Type 2 Diabetes (T2D). Insulin clearance represents one of the processes regulating glucose tolerance but has been scarcely investigated for its possible impairment in high-risk subjects. The aim of this study was to identify possible determinants of insulin clearance in women with a previous history of GDM. A detailed model-based analysis of a regular 3-hour, insulin-modified intravenous glucose tolerance test (IM-IVGTT) has been performed in women with a previous history of GDM (pGDM, n = 115) and in women who had a healthy pregnancy (CNT, n = 41) to assess total, first-phase and second-phase insulin clearance (Cl, Cl and Cl) and other metabolic parameters (insulin sensitivity S, glucose effectiveness S, beta-cell function and disposition index DI). CL was found increased in pGDM with respect to CNT and was found significantly inversely linearly correlated with S (r = -0.20, p = 0.03, slope: -16.2, 95% CI -30.9 to -1.4, intercept: 1.1, 95% CI 0.7-1.4) and also with DI (r = -0.22, p = 0.02, slope: -10.0, 95% CI -18.5 to -1.6, intercept: 0.9, 95% CI 0.7-1.3). Disposition index, accounting for the combined contribution of insulin sensitivity and beta-cell function, and glucose effectiveness were identified as possible determinants of insulin clearance in women with a previous history of GDM. This may be of relevance for more accurate estimation and prevention of the risk for recurrent GDM and T2D.
既往有妊娠期糖尿病(GDM)病史的女性在未来妊娠中发生GDM(即复发性GDM)以及2型糖尿病(T2D)的风险增加。胰岛素清除是调节糖耐量的过程之一,但在高危人群中其可能存在的受损情况鲜有研究。本研究的目的是确定既往有GDM病史女性胰岛素清除的可能决定因素。对既往有GDM病史的女性(pGDM,n = 115)和妊娠正常的女性(CNT,n = 41)进行了基于详细模型的常规3小时胰岛素改良静脉葡萄糖耐量试验(IM-IVGTT)分析,以评估总胰岛素清除率、第一相和第二相胰岛素清除率(Cl、Cl₁和Cl₂)以及其他代谢参数(胰岛素敏感性S、葡萄糖效能Sg、β细胞功能和处置指数DI)。发现pGDM组的CL高于CNT组,且与S呈显著负线性相关(r = -0.20,p = 0.03,斜率:-16.2,95%CI -30.9至-1.4,截距:1.1,95%CI 0.7 - 1.4),也与DI呈负相关(r = -0.22,p = 0.02,斜率:-10.0,95%CI -18.5至-1.6,截距:0.9,95%CI 0.7 - 1.3)。处置指数(综合考虑胰岛素敏感性和β细胞功能的作用)和葡萄糖效能被确定为既往有GDM病史女性胰岛素清除的可能决定因素。这可能对于更准确地估计和预防复发性GDM和T2D的风险具有重要意义。